Old Web
English
Sign In
Acemap
>
authorDetail
>
Andreas Hünnemeyer
Andreas Hünnemeyer
Nycomed
Pharmacology
Medicine
Roflumilast
Cmax
Pharmacokinetics
3
Papers
47
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Effects of steady-state female hormones on single-dose pharmacokinetics of roflumilast and roflumilast N-oxide
2011
European Respiratory Journal
Nassr Nassr
Andreas Hünnemeyer
Rolf Herzog
Joachim Scholpp
Gezim Lahu
Show All
Source
Cite
Save
Citations (0)
Population Pharmacokinetic Modelling of Roflumilast and Roflumilast N-Oxide by Total Phosphodiesterase-4 Inhibitory Activity and Development of a Population Pharmacodynamic-Adverse Event Model
2010
Clinical Pharmacokinectics
Gezim Lahu
Andreas Hünnemeyer
Edgar Diletti
Martin W. Elmlinger
Peter Ruth
Karl Zech
Nigel McCracken
Axel Facius
Show All
Source
Cite
Save
Citations (30)
The Targeted Oral, Once‐Daily Phosphodiesterase 4 Inhibitor Roflumilast and the Leukotriene Receptor Antagonist Montelukast Do Not Exhibit Significant Pharmacokinetic Interactions
2009
The Journal of Clinical Pharmacology
Gabriele M. Böhmer
Nassr Nassr
Marcus Wenger
Andreas Hünnemeyer
Gezim Lahu
Silke Templin
Christoph H. Gleiter
Robert Hermann
Show All
Source
Cite
Save
Citations (17)
1